Kestra Medical Technologies, Ltd. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Kestra Medical Technologies, Ltd. (KMTS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.52 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-07-31 was $9.52M, a 107.84% increase year-over-year.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-01-31 was $10.11M, a 2102.18% increase year-over-year.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-10-31 was $8.65M, a 671.21% increase year-over-year.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-07-31 was $4.58M, a 1114.59% increase year-over-year.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $33.64M, a 38.62% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $24.27M, a 1531.12% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.49M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-07-31 | $9.52M 10-Q · filed 2026-09-14 | |||
| 2026-04-30 | $33.64M 10-K · filed 2026-07-14 | |||
| 2026-01-31 | $10.11M 10-Q · filed 2026-03-17 | $18.76M derived: sum of 2 quarters · filed 2026-03-17 | $23.34M derived: sum of 3 quarters · filed 2026-09-14 | |
| 2025-10-31 | $8.65M 10-Q · filed 2026-03-17 | $13.23M derived: sum of 2 quarters · filed 2026-09-14 | ||
| 2025-07-31 | $4.58M 10-Q · filed 2026-09-14 | |||
| 2025-04-30 | $24.27M 10-K · filed 2026-07-14 | |||
| 2025-01-31 | $459.00K 10-Q · filed 2026-03-17 | $1.58M derived: sum of 2 quarters · filed 2026-03-17 | $1.96M derived: sum of 3 quarters · filed 2026-03-17 | |
| 2024-10-31 | $1.12M 10-Q · filed 2026-03-17 | $1.50M derived: sum of 2 quarters · filed 2026-03-17 | ||
| 2024-07-31 | $377.00K 10-Q · filed 2026-03-17 | |||
| 2024-04-30 | $1.49M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |